FDA Orange Book
Generic for Infumorph
Infumorph contains morphine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Infumorph is morphine. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.
Run it in Rivvi
Map Infumorph and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Infumorph products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | 10MG/ML | Marketed (Rx) | AP | 3 | AP |
| injectable, injection | 25MG/ML | Marketed (Rx) | AP | 1 | AP |
NDA 018565, held by HIKMA PHARMACEUTICALS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic morphine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| HIKMA PHARMACEUTICALS USA INC | 205758 | AP (A-rated, therapeutically equivalent) | May 21, 2015 | 10MG/ML |
| PIRAMAL CRITICAL CARE INC | 204393 | AP (A-rated, therapeutically equivalent) | July 16, 2018 | 10MG/ML, 25MG/ML |
| HIKMA PHARMACEUTICALS USA INC | 211452 | AP (A-rated, therapeutically equivalent) | January 12, 2023 | 10MG/ML |
Infumorph NDC codes
Questions
Is there a generic for Infumorph?
Yes. The generic name for Infumorph is morphine. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AP.
What is the generic name for Infumorph?
The active ingredient in Infumorph is morphine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.